1404 POSTER DISCUSSION Baseline (BL) IL-6, IL-8, and VEGF as Predictive and Prognostic Markers for Overall Survival (OS) in Metastatic Renal Cell Carcinoma (mRCC) Patients (pts) Treated in a Phase III Trial of Pazopanib (PAZO) Versus Placebo (PL)

✍ Scribed by Y. Liu; H.T. Tran; Y. Lin; A.M. Martin; A. Zurita; C.N. Sternberg; V.E.G. Team; R. Amado; L.N. Pandite; J.V. Heymach

• Book ID: 117661390
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 42 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(11)70897-8